Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
glp-1 shortage shortages news november 2025 FDA finalizes decision to end Lilly's GLP -1 shortage, analysts predict Novo will be next FDA's GLP-1 decision kicks off – Novo's Wegovy becomes first Buy More Save More:Double Pack bundle
Novo's Wegovy becomes first GLP-1 drug approved for MASH | BioPharma Dive
With dedicated support from a team of passionate clinical pharmacists and proven patient adherence solutions, your patients can be confident to start, continue, and benefit from their GLP-1 therapy
bundle
Buy More Save More:Double Pack
Our 2026 market reports now include enhanced strategic insights through: • Market attractiveness scoring and analysis • Total addressable market (TAM) analysis • Company scoring matrix graphics and tables • Excel-based forecasting dashboards • Market hotspots infographics • Key technologies and future trend analysis • Updated graphics and tables Reach out to us: The Business Research Company: Americas +1 310-496-7795, Europe +44 7882 955267, Asia & Others +44 7882 955267 & +91 8897263534, Email us at [email protected]
US$ 27.26
US$ 22.04
US$ 20.97
US$ 22.56
